VASTox, Alnylam, Hayashi Kasei | GenomeWeb

VASTox, Alnylam, Hayashi Kasei

VASTox Changes Name to Summit Corporation
Summit Corporation this week announced the completion of the company’s name change from VASTox. The change in name was approved by shareholders at the company’s annual shareholder’s meeting on July 19.

Alnylam Licenses siRNA Patents to Japanese Distributor Hayashi Kasei

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.